Mechanical Circulatory Support Korea Post Market Surveillance Study (PMS)

CompletedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

June 11, 2015

Primary Completion Date

December 5, 2020

Study Completion Date

December 5, 2020

Conditions
End-stage Heart Failure
Interventions
DEVICE

HeartWare Ventricular Assist Device

The Medtronic HVAD® System is comprised of three major components: the HVAD Pump with inflow and outflow conduits, a Controller and power sources. In addition to these components, the system includes a Monitor, Battery Charger, AC and DC power adapters, and a Carrying Case. The HVAD® System is indicated for hemodynamic support in patients with advanced, refractory left ventricular heart failure; either as a bridge to cardiac transplantation (BTT), myocardial recovery, or as destination therapy (DT) in patients for whom subsequent transplantation is not planned.

Trial Locations (2)

Unknown

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT04543747 - Mechanical Circulatory Support Korea Post Market Surveillance Study (PMS) | Biotech Hunter | Biotech Hunter